D-1067-2013 Class III Terminated

Recalled by Osmotica Pharmaceutical Corp — Marietta, GA

FDA drug recall D-1067-2013 was initiated by Osmotica Pharmaceutical Corp on Sep 16, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification:12 hour time point at 18 months of product shelf life. The recall status is terminated (terminated May 9, 2014). Affected quantity: 57857 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 9, 2013
Initiation Date
Sep 16, 2013
Termination Date
May 9, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
57857 bottles

Product description

Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.

Reason for recall

Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.

Distribution pattern

Nationwide

Code information

Lot #: a) 58975, 58976, 58977, 65165 , Exp 01/14; b) 58973, 58974, 65131, Exp: 01/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1067-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1067-2013. Report a data issue: hello@regdatalab.com.